upcoming glp-1 drugs New drug helps patients lose an average of 50 pounds Market Overview: GLP-1 Agonists and

J Nutr Biochem 2024:109622 Janczewski (2022) Sulforaphane and its bifunctional analogs: synthesis and biological activity

State Medicaid programs, already facing budget constraints, often prioritize diabetes indication over weight management, even though both represent FDA-approved uses with clinical evidence

#BPOMRI #HALOBPOM1500533 #PengawasanBPOM

Why Conventional Rosacea Treatment Often Falls Short Standard therapy usually includes: Topical metronidazole Azelaic acid Topical ivermectin Oral doxycycline Laser procedures These treatments may reduce visible inflammation, but many patients continue experiencing: Recurring flares Persistent flushing Heat sensitivity Food-triggered reactions Burning sensations This happens because the root inflammatory drivers are frequently left untreated